The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 21, 2023 Category: Cancer & Oncology Authors: Ángela BellaIgnacio MeleroPedro BerraondoFernando Arandaa Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spainb Navarra Institute for Health Research (IDISNA), Pamplona, Spainc Centro de Investigación Biomédica en Red d Source Type: research
Tumor-intrinsic RGS1 potentiates checkpoint blockade response via ATF3-IFNGR1 axis
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 21, 2023 Category: Cancer & Oncology Authors: Baojun WangBo JiangLin DuWenyuan ChenQing ZhangWei ChenMeng DingWenmin CaoJie GaoYongming DengYao FuYan LiYonglong XiaoWenli DiaoHongqian Guoa Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, N Source Type: research
Cell type-specific induction of ferroptosis to boost antitumor immunity
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 20, 2023 Category: Cancer & Oncology Authors: Jiao LiuJingbo LiRui KangDaolin Tanga DAMP Lab, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Chinab Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Chinac Department of Surgery, UT Source Type: research
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 13, 2023 Category: Cancer & Oncology Authors: Maximilian MarholdSimon UdovicaAnna HalsteadMona HirdlerMuna FernerKerstin WimmerZsuzsanna Bago-HorvathRuth ExnerFlorian FitzalKathrin Strasser-WeipplTim RobinsonRupert Bartscha Division of Oncology, Department for Medicine I, Medical University of Vienna Source Type: research
Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 10, 2023 Category: Cancer & Oncology Authors: Lucillia BezuOliver KeppGuido Kroemera Equipe Labellis ée Par La Ligue Contre Le Cancer, Université Paris Cité, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Institut Universitaire de France, Paris, Franceb Metabolomics and Source Type: research
Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 5, 2023 Category: Cancer & Oncology Authors: Nils-Petter RudqvistManushak AvagyanDhan ChandAgenus Inc, Lexington, MA, USA Source Type: research
Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - November 3, 2023 Category: Cancer & Oncology Authors: Iria Fernandez BotanaGiulia PaganoEtienne MoussayJerome Paggettia Tumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, Luxembourgb Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette Source Type: research
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 30, 2023 Category: Cancer & Oncology Authors: Pankti ReidSabina SandigurskyJuhee SongMaria A. Lopez-OlivoHoussein SafaSamuel CytrynElizaveta EfuniMaryam BuniAnna PavlickMichelle KrogsgaardOsama Abu-ShawerMehmet AltanJeffrey S. WeberOsama E. RahmaMaria E. Suarez-AlmazorAdi DiabNoha Abdel-Wahaba Divisi Source Type: research
Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 24, 2023 Category: Cancer & Oncology Authors: Sandra Garc ía-MuleroRoberto FornelinoMarco PuntaStefano LiseMar VarelaLuis P. del CarpioRafael MorenoMarcel Costa-GarcíaDietmar RiederZlatko TrajanoskiAlena GrosRamón AlemanyJosep María PiulatsRebeca Sanz-Pamplonaa Unit of Biomarkers and Susceptibili Source Type: research
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 20, 2023 Category: Cancer & Oncology Authors: Tao ZhangRamez WahibDimitra E. ZazaraJ öran LückeAhmad Mustafa ShiriJan KempskiLilan ZhaoTheodora AgaliotiAndres Pablo MachicoteOlympia GiannouIoannis BeliosRongrong JiaSiwen ZhangJoseph TintelnotHannes SeeseJulia Kristin GrassBaris MercanogluLouisa Ste Source Type: research
Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 20, 2023 Category: Cancer & Oncology Authors: Qikang HuMeredith L. FrankYang GaoLiyan JiMuyun PengChen ChenBin WangYan HuZeyu WuJina LiLu ShuQiongzhi HeYingqian ZhangXuefeng XiaJianjun ZhangXin YiAlexandre ReubenFenglei Yua Department of Thoracic Surgery, The Second Xiangya Hospital of Central South Source Type: research
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 19, 2023 Category: Cancer & Oncology Authors: Niklas Kl ümperLennert WüstJonas SaalDamian J. RalserRomina ZarblJonas JarczykJohannes BreyerDanijel SikicBernd WullichChristian BolenzFlorian RoghmannMichael HölzelManuel RitterSebastian StriethArndt HartmannPhilipp ErbenRalph M. WirtzJennifer Landsbe Source Type: research
A mitochondrial checkpoint to adaptive anticancer immunity
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 17, 2023 Category: Cancer & Oncology Authors: Oliver KeppPeng LiuGuido KroemerLorenzo Galluzzia Centre de Recherche des Cordeliers, Equipe labellis ée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Institut Universitaire de France, Paris, Franceb Metabolomic Source Type: research
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 17, 2023 Category: Cancer & Oncology Authors: Hayat B ähr-MahmudUrsula EllinghausChristiane R. StadlerLeyla FischerClaudia LindemannAnuhar ChaturvediJan DiekmannStefan WöllImke BiermannBernhard HebichCaroline ScharfManuela SiefkeAlexandra S. RothMartin RaoKerstin BrettschneiderEva-Maria EwenUğur Source Type: research
Dipeptidyl peptidase 4 inhibition sensitizes radiotherapy by promoting T cell infiltration
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - October 13, 2023 Category: Cancer & Oncology Authors: Yu TianLingyi KongYan LiZhiyun LiaoXing CaiSuke DengXiao YangBin ZhangYijun WangZhanjie ZhangBian WuLu WenFang HuangYan HuChao WanYifei LiaoYajie SunKunyu Yanga Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Tech Source Type: research
